Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02194816 · ClinicalTrials.gov registry record
Modifiable Variables in Parkinsonism (MVP)
A clinical trial of Parkinson's Disease and Dementia With Lewy Bodies, sponsored by Bastyr University.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT02194816: Recruiting study of Parkinson's Disease and Dementia With Lewy Bodies, sponsored by Bastyr University.
NCT02194816 is a study of Parkinson's Disease and Dementia With Lewy Bodies that is actively recruiting participants, run by Bastyr University. The registered enrollment target is 2,000 participants, above the 623-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (221% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02194816, a study of Parkinson's Disease and Dementia With Lewy Bodies, is actively recruiting participants, sponsored by Bastyr University.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
We are trying to identify factors associated with improved quality of life and fewer PD symptoms. We are attempting to identify practices, beliefs, and therapies used by individuals who report excellent quality of life, few PD symptoms, and reduced rates of progression. After agreeing to participate, we will ask participants to fill our questionnaires about their experience with PD, their health in general, along with their food intake every six months for five years.
Primary Outcome
This survey has been developed to identify the complementary and alternative therapies most commonly used by individuals with PD. Results will be reported with descriptive statistics.
Conditions Studied
Study Locations (1)
Washington
- Bastyr University - Kenmore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2012-09 |
| Est. Completion | 2030-12 |
What NCT02194816 shows while recruiting
NCT02194816 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 623-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (221% higher).
The record links to 9 conditions, with Parkinson's Disease appearing as the primary indexed condition, and to 0 interventions.
NCT02194816 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT02194816 about?
NCT02194816 is a clinical study titled "Modifiable Variables in Parkinsonism (MVP)". We are trying to identify factors associated with improved quality of life and fewer PD symptoms. We are attempting to identify practices, beliefs, and therapies used by individuals who report excellent quality of life, few PD symptoms, and reduced rates of progression. After agreeing to participate...
What is the current status of trial NCT02194816?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2012-09. Estimated completion is 2030-12.
What conditions does trial NCT02194816 study?
This clinical trial studies the following conditions: Parkinson's Disease, Dementia With Lewy Bodies, Progressive Supranuclear Palsy, Corticobasal Degeneration, Parkinsonism.
Who is sponsoring clinical trial NCT02194816?
This trial is sponsored by Bastyr University, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02194816 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02194816's enrollment target sits among peer trials
2,000 7th of 158 higher than 151 of 158 other Parkinson's Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson's Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Novel DBS Stimulation Patterns for Treatment of Parkinson's Disease
RECRUITING · NA
-
rTMS to Improve Cognition in Parkinson's
RECRUITING · Phase 1
-
Deep Brain Stimulation for Visuomotor Function in Parkinson's Disease
RECRUITING
-
Ketamine for Veterans With Parkinson's Disease
RECRUITING · Phase 2
-
Feasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease
RECRUITING · NA
-
PET Imaging Evaluation of [11C]SY08
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia